UPDATE - UBS Upgraded Accenture plc (ACN) to Buy; Strong Demand
Get Alerts ACN Hot Sheet
Price: $181.35 --0%
Rating Summary:
26 Buy, 17 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 12
Rating Summary:
26 Buy, 17 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 12
Join SI Premium – FREE
UPDATE - UBS upgraded Accenture plc (NYSE: ACN) from Neutral to Buy. PT increased from $54 to $63.
UBS analyst says, "Our upgrade is based on the following factors: 1) our checks indicate that clients have become less price sensitive and more quality focussed, and willing to pay a premium for ACN’s services. ACN is also seeing strong revenue momentum across all operating groups; 2) shift in client priorities from “run the business” to “grow the business”, and we believe that ACN’s service offering is optimally positioned to gain market share; 3) strong bookings likely to drive revenue growth."
"We have increased our F11 revs ests from $24.2B to $24.7B vs. cons. of $24.6B and our EPS ests from $3.20 to $3.27 vs. cons. of $3.26. We have increased our F12 revs ests from $26.0B to $26.9B vs. cons. of $26.6B and our EPS estimates from $3.54 to $3.75 vs. consensus of $3.67, based on our checks that indicate that decision makers continue to gravitate toward vendors that have long-track records, broad capabilities and strong balance sheets."
To see all upgrades/downgrades on shares of ACN, visit our Analyst Ratings page.
UBS analyst says, "Our upgrade is based on the following factors: 1) our checks indicate that clients have become less price sensitive and more quality focussed, and willing to pay a premium for ACN’s services. ACN is also seeing strong revenue momentum across all operating groups; 2) shift in client priorities from “run the business” to “grow the business”, and we believe that ACN’s service offering is optimally positioned to gain market share; 3) strong bookings likely to drive revenue growth."
"We have increased our F11 revs ests from $24.2B to $24.7B vs. cons. of $24.6B and our EPS ests from $3.20 to $3.27 vs. cons. of $3.26. We have increased our F12 revs ests from $26.0B to $26.9B vs. cons. of $26.6B and our EPS estimates from $3.54 to $3.75 vs. consensus of $3.67, based on our checks that indicate that decision makers continue to gravitate toward vendors that have long-track records, broad capabilities and strong balance sheets."
To see all upgrades/downgrades on shares of ACN, visit our Analyst Ratings page.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades TIC Solutions (TIC) to Neutral
- UBS Downgrades Vicinity Centers (VCX:AU) (CNRAF) to Neutral
- UBS Downgrades Alkane Resources (ALK:AU) to Neutral
Create E-mail Alert Related Categories
UpgradesRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share